The Medical Affairs Company
Delivering Comprehensive Pharma Solutions

The life sciences sector is ripe with breakthrough innovations that continually disrupt how businesses operate. However, this breakneck scientific evolution brings with it never-before-seen complexity that places tremendous pressure on pharma and biotech firms to process scientific data accurately and efficiently for diverse stakeholders like physicians, payers, and patients.

Alleviating this pressure is The Medical Affairs Company (TMAC), a full-service medical affairs solutions provider that offers comprehensive and strategic outsourcing capabilities, consulting services, and medical information support. TMAC is a subsidiary of Parexel, a leading contract research organization (CRO) that delivers ancillary best-in-class services like medical communications, pharmacovigilance, and regulatory support to its clientele.

“Our network within the industry, and the clients we serve, view us in a favorable light; and keep coming back to us for multiple assignments, which reflects our ability to provide the right consultations,” says David Hahn, Worldwide Head at TMAC.

TMAC is uniquely positioned in the market, featuring a culturally embedded customer service orientation that drives the boutique-like creation of bespoke solutions for each customer. Its services center on four key facets including medical affairs consulting, contracted field-based medical teams, a direct executive search function for hiring top industry professionals, and an all-inclusive medical information contact center. Through these competencies, TMAC offers full-spectrum development and execution for small to mid-size biopharma clients seeking to introduce a new compound to the market.

Recently, a client with a promising developmental compound approached TMAC to build a holistic medical affairs infrastructure that enables product commercialization backed by unmatched de-risking of emerging business challenges through maximum variable resource deployment. For this project, TMAC gained a deeper understanding of the client’s existing skillsets, resources, and processes, before developing a medical affairs strategy powered by best-suited tactics aligned with their desired timeline. Six months after the profitable launch of their compound, the client was acquired by a top pharmaceutical company that kept TMAC as a partner owing to the resounding success. The functional variable solution built into its business model was paramount in increasing the client’s valuation.

Our network within the industry, and the clients we serve, view us in a favorable light; and keep coming back to us for multiple assignments, which reflects our ability to provide the right consultations

Unlike its counterparts that primarily act as commercial solutions providers, TMAC approaches every engagement with an entrepreneurial and customer service mindset to deliver robust medical affairs support. Simultaneously, its in-house medical affairs consultants leverage their client-side and service-side expertise to engage with customers and bring multiple perspectives across product life cycles.

Over two decades, TMAC has successfully deployed over 4,000 medical science liaisons (MSL), clinical trial liaisons (CTL), and healthcare professionals on behalf of its customers worldwide. Today, it routinely synthesizes advanced scientific data and leverages technologies to offer the most efficient medical affairs strategy to the market. Moving forward, TMAC aims to continue delivering impactful insights, project management, and execution utilizing its unmatched experience, combined with a cultural alignment of putting relationships first.